Challenges in stem cell-derived islet replacement therapy can be overcome

Midhat H. Abdulreda, Per Olof Berggren

Research output: Contribution to journalComment/debatepeer-review


In this Commentary, we echo the conclusions of a recent review titled “The promise of stem cell-derived islet replacement therapy,” which highlighted recent advances in producing glucose responsive “islets” from stem cells and the benefits of their use in islet transplant therapy in type 1 diabetes (T1D). The review also outlined the status of clinical islet transplantation and the challenges that have prevented it from reaching its full therapeutic promise. We agree with the conclusions of the review and suggest that the identified challenges may be overcome by using the eye anterior chamber as an islet transplant site. We anticipate that the combination of stem cell-derived islets and intraocular transplant could help this promising T1D therapy reach full fruition.

Original languageEnglish (US)
JournalCell transplantation
StatePublished - 2021


  • anterior chamber of the eye
  • diabetes
  • glucose responsive
  • immune rejection
  • immune tolerance
  • insulin independence
  • insulin insufficiency
  • intraocular transplantation
  • islet transplant
  • stem cell-derived islets

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Challenges in stem cell-derived islet replacement therapy can be overcome'. Together they form a unique fingerprint.

Cite this